11:20 — a rheumatoid-arthritis review on a biologic.
Labs and the joint count feed a fresh DAS28 that TUCAN plots against the last four visits, showing the biologic is holding remission. The infusion log and monitoring labs sit in the same view, a structured visit note is drafted, and the matching GOÄ code is attached — so the treat-to-target decision is made with the full disease trajectory on screen, documented, and billable in one sitting.


